scholarly journals Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis

2017 ◽  
Vol 46 (10) ◽  
pp. 981-991 ◽  
Author(s):  
G. Stirnimann ◽  
T. Berg ◽  
L. Spahr ◽  
S. Zeuzem ◽  
S. McPherson ◽  
...  
2017 ◽  
Vol 10 (2) ◽  
pp. 283-292 ◽  
Author(s):  
Guido Stirnimann ◽  
Vanessa Banz ◽  
Federico Storni ◽  
Andrea De Gottardi

Cirrhotic patients with refractory ascites (RA) can be treated with repeated large volume paracentesis (LVP), with the insertion of a transjugular intrahepatic portosystemic shunt (TIPS) or with liver transplantation. However, side effects and complications of these therapeutic options, as well as organ shortage, warrant the development of novel treatments. The automated low-flow ascites pump (alfapump®) is a subcutaneously-implanted novel battery-driven device that pumps ascitic fluid from the peritoneal cavity into the urinary bladder. Ascites can therefore be aspirated in a time- and volume-controlled mode and evacuated by urination. Here we review the currently available data about patient selection, efficacy and safety of the alfapump and provide recommendations for the management of patients treated with this new method.


2019 ◽  
Vol 50 (9) ◽  
pp. 978-987 ◽  
Author(s):  
Antonia Lepida ◽  
Astrid Marot ◽  
Eric Trépo ◽  
Delphine Degré ◽  
Christophe Moreno ◽  
...  

2017 ◽  
Vol 3 (4) ◽  
pp. 20170025 ◽  
Author(s):  
Salil Karkhanis ◽  
Robert Jones ◽  
Andrew Willis ◽  
Eoghan Mccarthy ◽  
Zergham Zia ◽  
...  

2014 ◽  
Vol 60 (1) ◽  
pp. S244 ◽  
Author(s):  
A. De Gottardi ◽  
V. Banz ◽  
F. Storni ◽  
G. Stirnimann ◽  
N. Semmo ◽  
...  

2013 ◽  
Vol 58 (5) ◽  
pp. 922-927 ◽  
Author(s):  
Pablo Bellot ◽  
Martin-Walter Welker ◽  
German Soriano ◽  
Markus von Schaewen ◽  
Beate Appenrodt ◽  
...  

2021 ◽  
Vol 4 ◽  
pp. 100037
Author(s):  
Federico Storni ◽  
Jessica Stirnimann ◽  
Vanessa Banz ◽  
Andrea De Gottardi ◽  
Guido Stirnimann

2015 ◽  
Vol 400 (8) ◽  
pp. 979-983 ◽  
Author(s):  
M. N. Thomas ◽  
G. H. Sauter ◽  
A. L. Gerbes ◽  
M. Stangl ◽  
T. S. Schiergens ◽  
...  

2017 ◽  
Vol 46 (3) ◽  
pp. 1138-1145 ◽  
Author(s):  
Ruihong Zhao ◽  
Juan Lu ◽  
Yu Shi ◽  
Hong Zhao ◽  
Kaijin Xu ◽  
...  

Liver cirrhosis is a health problem worldwide, and ascites is its principal symptom. Refractory ascites is intractable and occurs in 5%–10% of all patients with ascites due to cirrhosis. Refractory ascites leads to a poor quality of life and high mortality rate. Ascites develops as a result of portal hypertension, which leads to water–sodium retention and renal failure. Various therapeutic measures can be used for refractory ascites, including large-volume paracentesis, transjugular intrahepatic portosystemic shunt, vasoconstrictive drugs, and an automated low-flow ascites pump system. However, ascites generally can be resolved only by liver transplantation. Because not all patients can undergo liver transplantation, traditional approaches are still used to treat refractory ascites. The choice of treatment modality for refractory ascites depends, among other factors, on the condition of the patient.


Sign in / Sign up

Export Citation Format

Share Document